grants_govRFA-AI-27-002
Open
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Response deadline
- Nov 10, 2026 Due in 68 days
- Date posted
- Sep 1, 2026
- Source
- Open notice
Description
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for an Infectious Diseases Clinical Trials Network (IDCTN). The IDCTN, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of interventions for emerging and chronic infections. The CTEUs design and implement clinical trials and studies, while the NCC provides the administrative and operational framework for a collaborative, integrated network and engages with experts in the field to solicit and generate clinical trial concepts. The NCC and CTEUs will collaboratively create opportunities to advance investigators early in their careers and those new to the field.
Classifications
- NAICS93.855
Documents (1)
- RFA-AI-27-002-Full-Announcement.htmltext/html;charset=UTF-8154 KBNot yet available
Contacts
Similar contracts
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)Due Nov 10, 2026
- Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)Due Jul 7, 2028
- Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)Due Sep 24, 2026
- Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed)Due Jul 1, 2028
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)Due Jul 5, 2029
- Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed)Due Jul 12, 2029